Even H. Rustad - Concepedia

Author

Even H. Rustad

Memorial Sloan Kettering Cancer Center ORCID

Also Known As

E H Rustad, Evan H. Rustad, Even H. Rustad, Even Holth Rustad, Even Rustad

296

Publications

872

Citations

H-Index

Concepts

All Affiliations

Memorial Sloan Kettering Cancer Center Norwegian University of Science and Technology St Olav's University Hospital Oslo University Hospital University of Milan

About

Even H. Rustad is an author at Memorial Sloan Kettering Cancer Center specializing in cancer research, immunology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	102
2	Immunology	3	3	102
3	Pathology	3	3	102
4	Cell Biology	1	1	23
5	Autoimmunity	1	1	23

Even H. Rustad

Publications

830

Citations

H-Index

Page 1

	Year	Citations
Timing the initiation of multiple myeloma Even H. Rustad, Venkata D. Yellapantula, Daniel Leongamornlert, Nature Communications	2020	157
Revealing the Impact of Structural Variants in Multiple Myeloma Even H. Rustad, Venkata Yellapantula, Dominik Głodzik, Blood Cancer Discovery	2020	124
Accelerated single cell seeding in relapsed multiple myeloma Heather Landau, Venkata D. Yellapantula, Benjamin Diamond, Nature Communications	2020	78
PDL1 Expression on Plasma and Dendritic Cells in Myeloma Bone Marrow Suggests Benefit of Targeted anti PD1-PDL1 Therapy Anne‐Marit Sponaas, Neda Nejati Moharrami, Emadoldin Feyzi, PLoS ONE	2015	75
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing Mattia D’Agostino, Gian Maria Zaccaria, Bachisio Ziccheddu, Clinical Cancer Research	2020	62
Monitoring multiple myeloma by quantification of recurrent mutations in serum Even H. Rustad, Eivind Coward, Emilie Ranheim Skytøen, Haematologica	2017	57
Comprehensive detection of recurring genomic abnormalities: a targeted sequencing approach for multiple myeloma Venkata D. Yellapantula, Malin Hultcrantz, Even H. Rustad, Blood Cancer Journal	2019	54
Molecular underpinnings of clinical disparity patterns in African American vs. Caucasian American multiple myeloma patients Dickran Kazandjian, Elizabeth Hill, Malin Hultcrantz, Blood Cancer Journal GeneticsImmunologyGenetic EpidemiologyPathologyHealth Disparities	2019	47
BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis Even H. Rustad, Hong Dai, H Hov, Blood Cancer Journal	2015	43
Baseline identification of clonal V(D)J sequences for DNA-based minimal residual disease detection in multiple myeloma Even H. Rustad, Malin Hultcrantz, Venkata Yellapantula, PLoS ONE Mixed-phenotype Acute LeukemiaImmunologyPathologyKappa Gene RearrangementsImmunotherapy	2019	32

Page 1